Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome
MM Brown, GC Brown, HC Brown… - Archives of …, 2009 - jamanetwork.com
Objective To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome
MM Brown, GC Brown, HC Brown, J Peet, Z Roth - 2009 - pubmed.ncbi.nlm.nih.gov
Objective To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
MM Brown, GC Brown, HC Brown, J Peet… - Arch …, 2009 - jamanetwork.com
Objective: To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
[引用][C] Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
MM BROWN, GC BROWN, HC BROWN… - Archives of …, 2009 - pascal-francis.inist.fr
Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical
Cyclosporine for the Treatment of Dry Eye Syndrome CNRS Inist Pascal-Francis CNRS Pascal …
Cyclosporine for the Treatment of Dry Eye Syndrome CNRS Inist Pascal-Francis CNRS Pascal …
Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome.
MM Brown, GC Brown, HC Brown, J Peet… - … (Chicago, Ill.: 1960), 2009 - europepmc.org
Objective To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
[PDF][PDF] Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
MM Brown, GC Brown, HC Brown, J Peet… - Arch …, 2009 - scholar.archive.org
Objective: To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
[PDF][PDF] Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
MM Brown, GC Brown, HC Brown, J Peet, Z Roth - Arch Ophthalmol, 2009 - academia.edu
Objective: To assess the comparative effectiveness and cost-effectiveness (cost-utility) of a
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …
0.05% emulsion of topical cyclosporine (Restasis; Allergan Inc, Irvine, California) for the …